Mefloquine disposition in normals and in patients with severe Plasmodium falciparum malaria.
Mefloquine pharmacokinetics were studied in Kenyan African normal volunteers and in patients with severe acute attack of Plasmodium falciparum malaria. Peak concentrations were achieved in both groups at 20-24 hours. The mean half-life of elimination was 385 +/- 150 hours (mean +/- SD) in normal subjects while in severe malaria it was 493 +/- 215 hours which was significantly longer (P less than or equal to 0.001). The volume of distribution was significantly smaller in severe malaria where it was 30.76 +/- 10.50 l/kg (mean +/- SD) while in the normal subjects it was 40.90 +/- 20.70 l/kg (mean +/- SD) (P less than or equal to 0.001). The total body clearance in severe malaria was 3.75 +/- 1.51 l/h (mean +/- SD). This was significantly lower than in the normal subjects where it was 5.15 +/- 1.50 l/h (mean +/- SD) (P less than or equal to 0.001).
Juma
F D
FD
Department of Clinical Pharmacology, University of Nairobi, Kenya.
Ogeto
J O
JO
D000328:Adult; D000818:Animals; D000962:Antimalarials / Q000493:pharmacokinetics*; D002851:Chromatography, High Pressure Liquid; D005260:Female; D006207:Half-Life; D006801:Humans; D008288:Malaria / Q000378:metabolism*; D008297:Male; D015767:Mefloquine; D010963:Plasmodium falciparum; D011804:Quinolines / Q000493:pharmacokinetics*
D000962:Antimalarials; D011804:Quinolines; D015767:Mefloquine